NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 211 filers reported holding NEVRO CORP in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $401,000 | +6.4% | 8,600 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $377,000 | -40.8% | 8,600 | -2.3% | 0.00% | -50.0% |
Q1 2022 | $637,000 | +2.4% | 8,800 | +14.7% | 0.00% | 0.0% |
Q4 2021 | $622,000 | -44.6% | 7,672 | -20.4% | 0.00% | -50.0% |
Q3 2021 | $1,122,000 | -59.4% | 9,642 | -42.1% | 0.00% | -63.6% |
Q2 2021 | $2,762,000 | -17.3% | 16,663 | -30.4% | 0.01% | -26.7% |
Q1 2021 | $3,341,000 | +421.2% | 23,952 | +420.7% | 0.02% | +400.0% |
Q3 2020 | $641,000 | -63.5% | 4,600 | -68.7% | 0.00% | -72.7% |
Q2 2020 | $1,756,000 | +278.4% | 14,700 | +216.8% | 0.01% | +175.0% |
Q1 2020 | $464,000 | -79.8% | 4,640 | -82.6% | 0.00% | -78.9% |
Q3 2019 | $2,296,000 | -0.7% | 26,710 | -25.1% | 0.02% | 0.0% |
Q2 2019 | $2,312,000 | +29.1% | 35,652 | +24.5% | 0.02% | +46.2% |
Q1 2019 | $1,791,000 | +22.8% | 28,644 | +12.0% | 0.01% | +62.5% |
Q3 2018 | $1,459,000 | -25.7% | 25,576 | +4.0% | 0.01% | -20.0% |
Q2 2018 | $1,964,000 | +691.9% | 24,585 | +759.6% | 0.01% | +400.0% |
Q1 2018 | $248,000 | +0.4% | 2,860 | +5.7% | 0.00% | +100.0% |
Q3 2017 | $247,000 | – | 2,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |